NanoCellect Biomedical Begins Distribution to Europe
San Diego, CA, May 01, 2019 --(PR.com)-- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG. The agreement covers sales in Switzerland of NanoCellect’s WOLF®Cell Sorter, N1 Single-Cell Dispenser, consumables and software. Bucher represents U.S. and European manufacturers of life science research instruments and associated reagents and consumables.
“Formalizing distributor relationships outside the United States is a key part of our growth strategy for 2019,” said Chris Neary, CEO of NanoCellect. “We are fortunate and excited to be working with the team at Bucher. We will benefit immediately from Bucher’s long-proven history of delivering and supporting innovative technology platforms to researchers in Switzerland, where we are seeing a great amount of interest in our gentle cell sorting solutions.”
"At Bucher Biotec, it is our highest priority to provide our Swiss customers access to the latest generation of biotech research tools to support evolving workflows,” said Marc Bucher, CEO of Bucher Biotec. “We consider the WOLF Cell Sorter to be highly unique, based on its sophisticated microfluidics, enabling gentle cell sorting and single cell dispensing in an easy-to-use platform. We are proud to be closely associated with the NanoCellect team and to introduce the WOLF sorter to our scientific community in Switzerland."
About Bucher Biotec AG
Bucher Biotec AG is a privately held Swiss company with a customer base in the pharmaceutical, biotechnology, agricultural, food and related industries. For over 40 years, Bucher serves life science research-oriented industrial and academic institutions, government, clinical and environmental labs and university hospitals
About NanoCellect Biomedical
NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on microfluidic technology. NanoCellect’s WOLF Cell Sorter and N1 single-cell plate dispenser provide gentle sorting to maintain cell viability. The WOLF platform is used in a growing list of application areas including antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing and plant and animal genomics. Founded in 2009, NanoCellect headquarters are in San Diego.
“Formalizing distributor relationships outside the United States is a key part of our growth strategy for 2019,” said Chris Neary, CEO of NanoCellect. “We are fortunate and excited to be working with the team at Bucher. We will benefit immediately from Bucher’s long-proven history of delivering and supporting innovative technology platforms to researchers in Switzerland, where we are seeing a great amount of interest in our gentle cell sorting solutions.”
"At Bucher Biotec, it is our highest priority to provide our Swiss customers access to the latest generation of biotech research tools to support evolving workflows,” said Marc Bucher, CEO of Bucher Biotec. “We consider the WOLF Cell Sorter to be highly unique, based on its sophisticated microfluidics, enabling gentle cell sorting and single cell dispensing in an easy-to-use platform. We are proud to be closely associated with the NanoCellect team and to introduce the WOLF sorter to our scientific community in Switzerland."
About Bucher Biotec AG
Bucher Biotec AG is a privately held Swiss company with a customer base in the pharmaceutical, biotechnology, agricultural, food and related industries. For over 40 years, Bucher serves life science research-oriented industrial and academic institutions, government, clinical and environmental labs and university hospitals
About NanoCellect Biomedical
NanoCellect is a life science tools company that develops and manufactures innovative solutions for cell analysis and sorting based on microfluidic technology. NanoCellect’s WOLF Cell Sorter and N1 single-cell plate dispenser provide gentle sorting to maintain cell viability. The WOLF platform is used in a growing list of application areas including antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing and plant and animal genomics. Founded in 2009, NanoCellect headquarters are in San Diego.
Contact
NanoCellect
Audra Nunnink
(877) 745-7678
www.nanocellect.com
Contact
Audra Nunnink
(877) 745-7678
www.nanocellect.com
Categories